Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)
- PMID: 32922516
- PMCID: PMC7450460
- DOI: 10.1177/1756286420949808
Gender issues of antibody-mediated diseases in neurology: (NMOSD/autoimmune encephalitis/MG)
Abstract
Neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are antibody-mediated neurological diseases. They have mostly female predominance, affecting many women during childbearing age. Interactions between the underlying disease (or necessary treatment) and pregnancy can occur in every of these illnesses. Herein, we present the characteristics of NMOSD, AE, MG and LEMS in general, and review published data regarding the influence of the different diseases on fertility, pregnancy, puerperium, treatment strategy during pregnancy and post-partum period, and menopause but also male factors. We summarise key elements that should be borne in mind when confronted with such cases.
Keywords: Lambert-Eaton myasthenic syndrome; autoimmune encephalitis; myasthenia gravis; neuromyelitis optica spectrum disease; pregnancy; sex differences; women.
© The Author(s), 2020.
Conflict of interest statement
Conflict of interest statement: Ayse Altintas has received speaker honoraria for non-promotional education events and travel grants from Merck, TEVA and Novartis. Christiane Schneider-Gold has received consulting and speaker’s honoraria from Alexion Pharmaceuticals, Amicus Therapeutics, Bayer Schering, CSL Behring, Grünenthal, Lupin Pharmaceuticals and TEVA. Andrea I. Ciplea has received speaker honoraria from Bayer Healthcare and travel grants from Sanofi Genzyme, Teva and Novartis. Frank Leypoldt discloses receiving speaker honoraria from Biogen, Roche, Merck, Fresenius, Teva, Bayer, Novartis, Alexion and advisory board memberships Roche, Biogen and Alexion. Kerstin Hellwig has received travel grants from Biogen, Novartis and Merck; received speaker and research honoraria from Biogen Idec Germany, Teva, Sanofi Genzyme, Novartis, Bayer Healthcare, Merck Serono and Roche. Frank Leypoldt, Klaus-Peter Wandinger, Justina Dargvainiene and Ralf Junker disclose working for an academic institution offering commercial antibody testing.
References
-
- Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112. - PubMed
-
- Reindl M, Di Pauli F, Rostásy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013; 9: 455–461. - PubMed
Publication types
LinkOut - more resources
Full Text Sources